Abstract

Dear Sir, We read with great interest the recent article by Shinohara et al., published in September 2008, concerning the role of interleukin-6 (IL-6) levels in cardiovascular autonomic dysfunction in patients with type 2 diabetes [1]. The study included 80 patients with type 2 diabetes without organic heart disease who were assigned to a high IL-6 group (>2.5 pg/ml, n=40, age 59±12 years) or a non-high IL-6 group (<2.5 pg/ml, n=40, age 61±12 years). Cardiac autonomic function was assessed by several methods including baroreflex sensitivity, heart rate variability, plasma norepinephrine concentrations and I-metaiodobenzylguanidine (MIBG) scintigraphy. The body mass index (BMI), fasting insulin levels, and homeostasis model assessment index values were higher in the high IL-6 group than in the non-high IL-6 group (p<0.01), while early and delayed I-MIBG myocardial uptake values were lower (p<0.01) and the percent washout rate was higher (p<0.05) in the high IL-6 group [1]. Multiple regression analysis revealed that the IL-6 level was independently predicted by the BMI and myocardial uptake of I-MIBG during the delayed phase [1]. Thus, the authors concluded that elevated IL-6 levels are associated with depressed cardiovascular autonomic function and obesity in patients with type 2 diabetes [1]. We refer to our experience investigating the clinical value of heart-rate recovery (HRR) in diabetic patients. The rise in heart rate during exercise is considered to be a direct consequence of sympathetic activation combined with parasympathetic withdrawal, whereas the decline in heart rate immediately after exercise is thought to be a function of reactivation of parasympathetic tone [2]. The reduction in heart rate from its value at peak exercise to the rate 1 min later is generally taken as the HRR [3]. The autonomic nervous system has a profound effect on myocardial pathophysiology, while autonomic neuropathy is a common complication in diabetic patients, particularly in those using insulin [4, 5]. In addition, it has been previously reported that fasting plasma glucose and plasma insulin levels are closely correlated with changes in cardiac autonomic function and impaired HRR [4]. The pathophysiology of abnormal HRR involves the inability to slow the heart immediately after exercise, which has been previously shown to be a marker of decreased vagal activity [2, 3]. Attenuated HRR after exercise testing has been found to be an independent predictor of cardiac and all-cause mortality in patients referred for exercise electrocardiography, while diabetes mellitus is associated with increased mortality from cardiovascular disease [3, 5–7]. Studying 206 diabetic patients, we have found a significant correlation (p<0.001) between HRR and myocardial ischaemia scintigraphic variables (summed stress score and summed difference score) [8]. Moreover, the calculation of HRR value during exercise testing could provide additional information and an incremental value (compared to clinical and exercise testing data) for the detection of myocardial ischaemia [8]. In addition, we have found a significant association between chronotropic variables during exercise testing and HRR [8]. Furthermore, we have recently reported our results of a study evaluating the usefulness of HRR after treadmill testing as a long-term prognostic marker of cardiovascular morbidity and mortalEur J Nucl Med Mol Imaging (2009) 36:320–321 DOI 10.1007/s00259-008-0982-z

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call